Wells Fargo’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16
| Closed | -$147 | – | 7304 |
|
|
2025
Q1 | $147 | Hold |
16
| – | – | ﹤0.01% | 6347 |
|
|
2024
Q4 | $107 | Sell |
16
-1
| -6% | -$9 | ﹤0.01% | 6407 |
|
|
2024
Q3 | $168 | Sell |
17
-14
| -45% | -$204 | ﹤0.01% | 6239 |
|
|
2024
Q2 | $484 | Sell |
31
-1,441
| -98% | -$24.1K | ﹤0.01% | 6149 |
|
|
2024
Q1 | $32.2K | Buy |
1,472
+195
| +15% | +$4.33K | ﹤0.01% | 5422 |
|
|
2023
Q4 | $24.7K | Buy |
1,277
+287
| +29% | +$5.24K | ﹤0.01% | 5552 |
|
|
2023
Q3 | $18.3K | Sell |
990
-1,058
| -52% | -$19K | ﹤0.01% | 5637 |
|
|
2023
Q2 | $37.8K | Buy |
2,048
+1,995
| +3,764% | +$47.2K | ﹤0.01% | 5534 |
|
|
2023
Q1 | $1.54K | Buy |
53
+13
| +33% | +$346 | ﹤0.01% | 6274 |
|
|
2022
Q4 | $1.1K | Sell |
40
-1,153
| -97% | -$43.8K | ﹤0.01% | 6155 |
|
|
2022
Q3 | $65K | Buy |
1,193
+1,148
| +2,551% | +$63K | ﹤0.01% | 4826 |
|
|
2022
Q2 | $3K | Buy |
45
+28
| +165% | +$1.03K | ﹤0.01% | 6204 |
|
|
2022
Q1 | $1K | Hold |
17
| – | – | ﹤0.01% | 6840 |
|
|
2021
Q4 | $0 | Sell |
17
-14
| -45% | -$469 | ﹤0.01% | 7645 |
|
|
2021
Q3 | $2K | Sell |
31
-1
| -3% | -$42 | ﹤0.01% | 6583 |
|
|
2021
Q2 | $2K | Sell |
32
-717
| -96% | -$36.6K | ﹤0.01% | 6549 |
|
|
2021
Q1 | $41K | Sell |
749
-3,840
| -84% | -$234K | ﹤0.01% | 5908 |
|
|
2020
Q4 | $286K | Buy |
4,589
+1,214
| +36% | +$74.4K | ﹤0.01% | 4895 |
|
|
2020
Q3 | $197K | Sell |
3,375
-822
| -20% | -$60.9K | ﹤0.01% | 4972 |
|
|
2020
Q2 | $469K | Buy |
4,197
+1,109
| +36% | +$78.9K | ﹤0.01% | 4374 |
|
|
2020
Q1 | $208K | Buy |
3,088
+592
| +24% | +$59.6K | ﹤0.01% | 4662 |
|
|
2019
Q4 | $345K | Buy |
2,496
+1,546
| +163% | +$201K | ﹤0.01% | 4643 |
|
|
2019
Q3 | $100K | Buy |
950
+449
| +90% | +$44.8K | ﹤0.01% | 5316 |
|
|
2019
Q2 | $53K | Sell |
501
-128
| -20% | -$16.9K | ﹤0.01% | 5529 |
|
|
2019
Q1 | $97K | Sell |
629
-1
| -0.2% | -$116 | ﹤0.01% | 5135 |
|
|
2018
Q4 | $59K | Sell |
630
-19,570
| -97% | -$2.79M | ﹤0.01% | 5469 |
|
|
2018
Q3 | $3.77M | Sell |
20,200
-10,077
| -33% | -$2.87M | ﹤0.01% | 2890 |
|
|
2018
Q2 | $12.7M | Buy |
30,277
+11,358
| +60% | +$3.83M | ﹤0.01% | 1870 |
|
|
2018
Q1 | $5.68M | Sell |
18,919
-101
| -0.5% | -$28K | ﹤0.01% | 2523 |
|
|
2017
Q4 | $5.39M | Buy |
+19,020
| New | +$5.35M | ﹤0.01% | 2518 |
|
Wells Fargo's OPTN Position: Q2 2025 in Review
Wells Fargo sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 16 shares — an estimated $147 sold.
Wells Fargo first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $12.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Wells Fargo reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Wells Fargo sold 16 OptiNose shares in Q2 2025, an estimated $147.
- Wells Fargo first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- Wells Fargo's OptiNose position peaked at $12.7M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.